Researchers at the American Federation for Aging Research are launching the TAME trial, a six-year series of studies aimed to see if cheap diabetes drug Metformin can increase lifespan. Read this story
Researchers at the American Federation for Aging Research are launching the TAME trial, a six-year series of studies aimed to see if cheap diabetes drug Metformin can increase lifespan. Read this story
More from dailym.ai | dailymail health Cancer FDA North Carolina Diabetes France